The study of proteins circulating in blood offers tremendous opportunities to diagnose,
stratify, or possibly prevent diseases. With recent technological advances and the urgent …

Despite many years of research, no biomarkers for stroke are available to use in clinical
practice. Progress in high-throughput technologies has provided new opportunities to …

The proteomic analysis of human blood and blood-derived products (eg, plasma) offers an
attractive avenue to translate research progress from the laboratory into the clinic. However …

Stroke remains a leading cause of death and disability, with limited therapeutic options and
suboptimal tools for diagnosis and prognosis. High throughput technologies such as …

Importance Sex differences have been described in the presentation, care, and outcomes
among people with acute ischemic strokes, but these differences are less understood for …

Proteomics, the simultaneous study of all proteins in a given cell, tissue or organism, is an
innovative approach used to identify novel markers for diagnosis, prognosis and the …

Blood-based protein biomarker signatures might be an alternative or supplement to existing
methods for early detection of colorectal cancer (CRC) for population-based screening. The …

Background The relationship between duration of transient neurological events and
presence of diffusion‐weighted lesions by symptom type is unclear. Methods and Results …

Introduction: Biospecimens and associated data are invaluable tools in Genomics and
Personalized Health (GAPH) research and can aid in the discovery of disease etiology and …

Background and Objective The association between focal vs nonfocal presenting symptom
and diffusion-weighted imaging (DWI) positivity in relation to onset-to-imaging time in …